192 related articles for article (PubMed ID: 17659579)
41. Probiotics in critically ill patients.
Madsen K
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S116-8. PubMed ID: 18806700
[TBL] [Abstract][Full Text] [Related]
42. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.
Lee HS; Han SY; Bae EA; Huh CS; Ahn YT; Lee JH; Kim DH
Int Immunopharmacol; 2008 Apr; 8(4):574-80. PubMed ID: 18328449
[TBL] [Abstract][Full Text] [Related]
43. The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction.
Ponferrada A; Caso JR; Alou L; Colón A; Sevillano D; Moro MA; Lizasoain I; Menchén P; Gómez-Lus ML; Lorenzo P; Cos E; Leza JC; Menchén L
Gastroenterology; 2007 May; 132(5):1791-803. PubMed ID: 17484875
[TBL] [Abstract][Full Text] [Related]
44. Role of probiotic bacteria in sepsis.
Fujita T
Hepatology; 2008 Apr; 47(4):1422; author reply 1422-3. PubMed ID: 18366113
[No Abstract] [Full Text] [Related]
45. [Intestinal cytokine liberation after intestinal ischemia in the rat--studies in the Ussing chamber system].
Grotz M; Regel G; Schratt HE; Seekamp A; Pape HC; Tscherne H
Z Gastroenterol; 1996 Dec; 34(12):783-90. PubMed ID: 9082659
[TBL] [Abstract][Full Text] [Related]
46. Recurrent bacterial translocation from gut and sepsis in Head and neck cancer patients and its prevention by probiotics.
Gunduz M; Murakami D; Gunduz I; Tamagawa S; Hiraoka M; Sugita G; Hotomi M
Med Hypotheses; 2018 Nov; 120():124-127. PubMed ID: 30220331
[TBL] [Abstract][Full Text] [Related]
47. Necroptosis Underlies Hepatic Damage in a Piglet Model of Lipopolysaccharide-Induced Sepsis.
Xu Q; Guo J; Li X; Wang Y; Wang D; Xiao K; Zhu H; Wang X; Hu CA; Zhang G; Liu Y
Front Immunol; 2021; 12():633830. PubMed ID: 33777021
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance of translocation.
Van Leeuwen PA; Boermeester MA; Houdijk AP; Ferwerda CC; Cuesta MA; Meyer S; Wesdorp RI
Gut; 1994 Jan; 35(1 Suppl):S28-34. PubMed ID: 8125386
[TBL] [Abstract][Full Text] [Related]
49. Exposure to ingested airborne pollutant particulate matter increases mucosal exposure to bacteria and induces early onset of inflammation in neonatal IL-10-deficient mice.
Salim SY; Jovel J; Wine E; Kaplan GG; Vincent R; Thiesen A; Barkema HW; Madsen KL
Inflamm Bowel Dis; 2014 Jul; 20(7):1129-38. PubMed ID: 24859295
[TBL] [Abstract][Full Text] [Related]
50. The Role of Probiotics in Lipopolysaccharide-Induced Autophagy in Intestinal Epithelial Cells.
Han C; Ding Z; Shi H; Qian W; Hou X; Lin R
Cell Physiol Biochem; 2016; 38(6):2464-78. PubMed ID: 27309845
[TBL] [Abstract][Full Text] [Related]
51. Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARγ and peptidoglycan recognition protein 3.
Zenhom M; Hyder A; de Vrese M; Heller KJ; Roeder T; Schrezenmeir J
J Nutr; 2011 May; 141(5):971-7. PubMed ID: 21451128
[TBL] [Abstract][Full Text] [Related]
52. The role of thermal injury on intestinal bacterial translocation and the mitigating role of probiotics: A review of animal and human studies.
Knackstedt R; Gatherwright J
Burns; 2020 Aug; 46(5):1005-1012. PubMed ID: 31351819
[TBL] [Abstract][Full Text] [Related]
53. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota.
Fang D; Shi D; Lv L; Gu S; Wu W; Chen Y; Guo J; Li A; Hu X; Guo F; Ye J; Li Y; Li L
Sci Rep; 2017 Aug; 7(1):8770. PubMed ID: 28821814
[TBL] [Abstract][Full Text] [Related]
54. Different cytokine response of primary colonic epithelial cells to commensal bacteria.
Lan JG; Cruickshank SM; Singh JC; Farrar M; Lodge JP; Felsburg PJ; Carding SR
World J Gastroenterol; 2005 Jun; 11(22):3375-84. PubMed ID: 15948242
[TBL] [Abstract][Full Text] [Related]
55. Prophylactic
Lapiere A; Geiger M; Robert V; Demarquay C; Auger S; Chadi S; Benadjaoud M; Fernandes G; Milliat F; Langella P; Benderitter M; Chatel JM; Sémont A
Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 32985332
[TBL] [Abstract][Full Text] [Related]
56. Genomics can advance the potential for probiotic cultures to improve liver and overall health.
O'Sullivan DJ
Curr Pharm Des; 2008; 14(14):1376-81. PubMed ID: 18537660
[TBL] [Abstract][Full Text] [Related]
57. Pretreatment With
Li YT; Ye JZ; Lv LX; Xu H; Yang LY; Jiang XW; Wu WR; Shi D; Fang DQ; Bian XY; Wang KC; Wang QQ; Xie JJ; Lu YM; Li LJ
Front Microbiol; 2019; 10():1751. PubMed ID: 31417535
[No Abstract] [Full Text] [Related]
58. Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis.
Rychter JW; van Minnen LP; Verheem A; Timmerman HM; Rijkers GT; Schipper ME; Gooszen HG; Akkermans LM; Kroese AB
Surgery; 2009 Feb; 145(2):157-67. PubMed ID: 19167970
[TBL] [Abstract][Full Text] [Related]
59. Probiotic as a novel treatment strategy against liver disease.
Imani Fooladi AA; Mahmoodzadeh Hosseini H; Nourani MR; Khani S; Alavian SM
Hepat Mon; 2013 Feb; 13(2):e7521. PubMed ID: 23610585
[TBL] [Abstract][Full Text] [Related]
60. Probiotics and gut health: a special focus on liver diseases.
Gratz SW; Mykkanen H; El-Nezami HS
World J Gastroenterol; 2010 Jan; 16(4):403-10. PubMed ID: 20101763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
